These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9920842

  • 1. Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
    Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y, Ishida Y, Fujita S.
    Blood; 1999 Feb 01; 93(3):925-35. PubMed ID: 9920842
    [Abstract] [Full Text] [Related]

  • 2. Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.
    Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S.
    Blood; 2000 Apr 01; 95(7):2352-5. PubMed ID: 10733506
    [Abstract] [Full Text] [Related]

  • 3. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M, Ohminami H, Yakushijin Y, Arai J, Hasegawa A, Ishida Y, Fujita S.
    J Immunol; 1999 May 15; 162(10):6100-6. PubMed ID: 10229852
    [Abstract] [Full Text] [Related]

  • 4. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
    Yanai F, Ishii E, Kojima K, Hasegawa A, Azuma T, Hirose S, Suga N, Mitsudome A, Zaitsu M, Ishida Y, Shirakata Y, Sayama K, Hashimoto K, Yasukawa M.
    J Immunol; 2003 Feb 15; 170(4):2205-13. PubMed ID: 12574394
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes.
    Traidl C, Sebastiani S, Albanesi C, Merk HF, Puddu P, Girolomoni G, Cavani A.
    J Immunol; 2000 Sep 15; 165(6):3058-64. PubMed ID: 10975816
    [Abstract] [Full Text] [Related]

  • 7. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
    Kataoka T, Shinohara N, Takayama H, Takaku K, Kondo S, Yonehara S, Nagai K.
    J Immunol; 1996 May 15; 156(10):3678-86. PubMed ID: 8621902
    [Abstract] [Full Text] [Related]

  • 8. Two distinct mechanisms of cytotoxicity mediated by herpes simplex virus-specific CD4+ human cytotoxic T cell clones.
    Yasukawa M, Yakushijin Y, Fujita S.
    Clin Immunol Immunopathol; 1996 Jan 15; 78(1):70-6. PubMed ID: 8599887
    [Abstract] [Full Text] [Related]

  • 9. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI, Brown GR, Thiele DL.
    J Immunol; 2001 Aug 01; 167(3):1566-74. PubMed ID: 11466378
    [Abstract] [Full Text] [Related]

  • 10. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T, Miyake Y, Kakeya H, Osada H, Kataoka T.
    J Immunol; 2004 Mar 15; 172(6):3428-36. PubMed ID: 15004142
    [Abstract] [Full Text] [Related]

  • 11. CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.
    Canaday DH, Wilkinson RJ, Li Q, Harding CV, Silver RF, Boom WH.
    J Immunol; 2001 Sep 01; 167(5):2734-42. PubMed ID: 11509617
    [Abstract] [Full Text] [Related]

  • 12. Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures.
    Frost PJ, Butterfield LH, Dissette VB, Economou JS, Bonavida B.
    J Immunol; 2001 Mar 01; 166(5):3564-73. PubMed ID: 11207317
    [Abstract] [Full Text] [Related]

  • 13. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
    Yang S, Haluska FG.
    J Immunol; 2004 Apr 01; 172(7):4599-608. PubMed ID: 15034078
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic T cells specifically induce Fas on target cells, thereby facilitating exocytosis-independent induction of apoptosis.
    Simon MM, Waring P, Lobigs M, Nil A, Tran T, Hla RT, Chin S, Müllbacher A.
    J Immunol; 2000 Oct 01; 165(7):3663-72. PubMed ID: 11034370
    [Abstract] [Full Text] [Related]

  • 15. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y, Thoburn CJ, Bright EC, Hess AD.
    Biol Blood Marrow Transplant; 2004 Mar 01; 10(3):156-70. PubMed ID: 14993881
    [Abstract] [Full Text] [Related]

  • 16. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent.
    Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B.
    Cancer Immunol Immunother; 1997 Jul 01; 44(5):282-90. PubMed ID: 9247563
    [Abstract] [Full Text] [Related]

  • 17. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones.
    Gagnon SJ, Ennis FA, Rothman AL.
    J Virol; 1999 May 01; 73(5):3623-9. PubMed ID: 10196254
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP, Hoskin DW.
    J Immunol; 1997 Nov 15; 159(10):4700-7. PubMed ID: 9366393
    [Abstract] [Full Text] [Related]

  • 19. CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis.
    Muta H, Boise LH, Fang L, Podack ER.
    J Immunol; 2000 Nov 01; 165(9):5105-11. PubMed ID: 11046041
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.
    Yu Y, Hagihara M, Ando K, Gansuvd B, Matsuzawa H, Tsuchiya T, Ueda Y, Inoue H, Hotta T, Kato S.
    J Immunol; 2001 Feb 01; 166(3):1590-600. PubMed ID: 11160200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.